Persistence of wild-type virus and lack of temporal structure in the latent reservoir for human immunodeficiency virus type 1 in pediatric patients with extensive antiretroviral exposure

被引:114
作者
Ruff, CT
Ray, SC
Kwon, P
Zinn, R
Pendleton, A
Hutton, N
Ashworth, R
Gange, S
Quinn, TC
Siliciano, RF
Persaud, D
机构
[1] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA
[2] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA
[3] Johns Hopkins Univ, Sch Med, Inst Med Genet, Baltimore, MD 21205 USA
[4] NIAID, NIH, Bethesda, MD 20892 USA
[5] Johns Hopkins Univ, Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA
关键词
D O I
10.1128/JVI.76.18.9481-9492.2002
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Although highly active antiretroviral therapy (HAART) for human immunodeficiency virus type 1 (HIV-1) infection can reduce levels of HIV-1 RNA in plasma to below the limit of detection, replication-competent forms of the virus persist in all infected individuals. One form of persistence involves a stable reservoir of latent but potentially infectious virus that resides in resting memory CD4(+) T cells. The mechanisms involved in maintaining this latent reservoir are incompletely understood. In the present study, we examined the dynamic characteristics of this reservoir in a cohort of children who developed drug-resistant HIV-1 as a result of extensive exposure to inadequately suppressive one- or two-drug regimens prior to the advent of HAART. We have previously shown that drug-resistant viruses selected by nonsuppressive pre-HAART regimens can enter and persist in this reservoir. We have extended these findings here by demonstrating that archival wild-type HIV-1 persists in this reservoir despite the fact that in these patients drug-resistant mutants have been favored by the selective conditions for many years. Phylogenetic analysis of replication-competent viruses persisting in resting CD4(+) T cells revealed a striking lack of temporal structure in the sense that isolates obtained at later time points did not show greater sequence divergence than isolates from earlier time points. The persistence of drug-sensitive virus and the lack of temporal structure in the latent reservoir provide genetic evidence for the idea that HIV-1 can persist in a latent form free of selective pressure from antiretroviral drugs in long-lived resting memory CD4(+) T cells. Although there may be other mechanisms for viral persistence, this stable pool of latently infected cells is of significant concern because of its potential to serve as a lasting source of replication-competent viruses, including the infecting wild-type form and all drug-resistant variants that have arisen subsequently.
引用
收藏
页码:9481 / 9492
页数:12
相关论文
共 40 条
[1]   Biphasic decay of latently infected CD4+ T cells in acute human immunodeficiency virus type 1 infection [J].
Blankson, JN ;
Finzi, D ;
Pierson, TC ;
Sabundayo, BP ;
Chadwick, K ;
Margolick, JB ;
Quinn, TC ;
Siliciano, RF .
JOURNAL OF INFECTIOUS DISEASES, 2000, 182 (06) :1636-1642
[2]   The challenge of viral reservoirs in HIV-1 infection [J].
Blankson, JN ;
Persaud, D ;
Siliciano, RF .
ANNUAL REVIEW OF MEDICINE, 2002, 53 :557-593
[3]   QUIESCENT LYMPHOCYTES-T AS AN INDUCIBLE VIRUS RESERVOIR IN HIV-1 INFECTION [J].
BUKRINSKY, MI ;
STANWICK, TL ;
DEMPSEY, MP ;
STEVENSON, M .
SCIENCE, 1991, 254 (5030) :423-427
[4]   Relationship between pre-existing viral reservoirs and the re-emergence of plasma viremia after discontinuation of highly active anti-retroviral therapy [J].
Chun, TW ;
Davey, RT ;
Ostrowski, M ;
Justement, JS ;
Engel, D ;
Mullins, JI ;
Fauci, AS .
NATURE MEDICINE, 2000, 6 (07) :757-761
[5]   IN-VIVO FATE OF HIV-1-INFECTED T-CELLS - QUANTITATIVE-ANALYSIS OF THE TRANSITION TO STABLE LATENCY [J].
CHUN, TW ;
FINZI, D ;
MARGOLICK, J ;
CHADWICK, K ;
SCHWARTZ, D ;
SILICIANO, RF .
NATURE MEDICINE, 1995, 1 (12) :1284-1290
[6]   Quantification of latent tissue reservoirs and total body viral load in HIV-1 Infection [J].
Chun, TW ;
Carruth, L ;
Finzi, D ;
Shen, XF ;
DiGiuseppe, JA ;
Taylor, H ;
Hermankova, M ;
Chadwick, K ;
Margolick, J ;
Quinn, TC ;
Kuo, YH ;
Brookmeyer, R ;
Zeiger, MA ;
BarditchCrovo, P ;
Siliciano, RF .
NATURE, 1997, 387 (6629) :183-188
[7]   Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy [J].
Chun, TW ;
Stuyver, L ;
Mizell, SB ;
Ehler, LA ;
Mican, JAM ;
Baseler, M ;
Lloyd, AL ;
Nowak, MA ;
Fauci, AS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (24) :13193-13197
[8]  
de Mendoza C, 2000, J ACQ IMMUN DEF SYND, V23, P279
[9]   Virologic and immunologic consequences of discontinuing combination antiretroviral-drug therapy in HIV-infected patients with detectable viremia. [J].
Deeks, SG ;
Wrin, T ;
Liegler, T ;
Hoh, R ;
Hayden, M ;
Barbour, JD ;
Hellmann, NS ;
Petropoulos, CJ ;
McCune, JM ;
Hellerstein, MK ;
Grant, RM .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (07) :472-480
[10]   Residual HIV-1 RNA in blood plasma of patients taking suppressive highly active antiretroviral therapy [J].
Dornadula, G ;
Zhang, H ;
VanUitert, B ;
Stern, J ;
Livornese, L ;
Ingerman, MJ ;
Witek, J ;
Kedanis, RJ ;
Natkin, J ;
DeSimone, J ;
Pomerantz, RJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (17) :1627-1632